Skip to content

Effect of Promethazine and Midazolam on preoperative anxiety

Comparison of oral Promethazine's effect with Midazolam and with Placebo on preoperative anxiety in children (3-8 years old)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012073010447N1
Enrollment
123
Registered
2012-09-24
Start date
2012-07-17
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety. Neurotic, stress-related and somatoform disorders

Interventions

Intervention 1: Midazolam group: Midazolam syrup (Producted by Midazolam ampule and juice) / Two milligram (mg) in 1 milliliter (ml) / Midazolam Chloridric Acid / With single dose of 0.5 mg per kilog
Treatment - Drugs
Midazolam group: Midazolam syrup (Producted by Midazolam ampule and juice) / Two milligram (mg) in 1 milliliter (ml) / Midazolam Chloridric Acid / With single dose of 0.5 mg per kilogram (kg) up to a
Promethazine group: Promethazine syrup / Promethazine Chloridric Acid / With single dose of 0.5 mg per kg up to a maximum of 20 mg / Five mg in 5 ml / Oral / Once and two hours before surgery / Tehra
Control group: Oral / Injection water / With single dose of 2-5 ml / Once and 2 hours before surgery / Dana Company / Brand name: Injection water

Sponsors

Lorestan University of Medical Sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Children with 3-8 years old / With American Society of Anaesthesiologists (ASA) grade 1 and 2 / under general anaesthesia / elective surgery / lack of chronic disease, prematurity, growth retardation, brain disorders, vision and acoustic disorders / with a written consent form from parents. Exclusion criteria: History of allergy to used drugs in this study / Children with emergency surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Preoperative anxiety. Timepoint: Before intervention, One hours and 30 minutes after intervention ( Separation's time of child from parent) , Two hours after intervention (Before induction of anaesthesia). Method of measurement: According to Yale Preoperative Anxiety Scoring (YPAS) by questionnaire.

Secondary

MeasureTime frame
Age. Timepoint: Before intervention. Method of measurement: According to number of year by questionnaire.;Sex. Timepoint: Before intervention. Method of measurement: According to phenotype by questionnaire.;Blood pressure (BP). Timepoint: Before intervention, Two hours after intervention. Method of measurement: According to millimeter of Mercury by barometer.;Pulse rate (PR). Timepoint: Before intervention, Two hours after intervention. Method of measurement: According to number of heartbeat in minute by physical exam.;Respiratory rate (RR). Timepoint: Before intervention, Two hours after intervention. Method of measurement: According to number of breathing in minute by physical exam.;Nausea and vomiting. Timepoint: Before intervention, After surgery. Method of measurement: According to yes or no by questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sedighe Nadri

Lorestan University of Medical Sciences

nadri.s@lums.ac.ir+98 6616200155169

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026